We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




In Patients with Early Breast Cancer, Intensity-Modulated Radiotherapy Reduces Side Effects

By HospiMedica International staff writers
Posted on 16 May 2013
Intensity-modulated radiotherapy (IMRT) provides better results than
conventional radiotherapy in patients with early breast cancer, according to new findings. More...


The randomized trial findings were presented April 22, 2013, at the 2nd
Forum of the European Society for Radiotherapy and Oncology (ESTRO), held in Geneva (Switzerland). IMRT is an advanced, high-precision form of
radiotherapy that can deliver an even dose of radiation, thus reducing the cosmetic problems that can often occur after breast radiotherapy.

“We believe that this study, the largest prospective trial in the world to
test breast IMRT against standard two-dimensional radiotherapy, will be
practice-changing at an international level,” said Dr. Charlottes Coles, from Addenbrooke’s Hospital Oncology Center (Cambridge, UK) “Analyzing the results five years after treatment, we saw significant benefits in patients who had received IMRT.”

Researchers analyzed the radiotherapy treatment plans of 1,145 patients
with early breast cancer who had previously had breast-conserving surgery. The plans were screened to see if they would produce an uneven radiation dose with standard two-dimensional radiotherapy (2DRT). Seventy-one percent of the plans fell into this classification, and those patients were randomized between conventional 2DRT and IMRT. The 29% of patients whose plans would not produce an uneven dose were treated with standard 2DRT, but still followed up within the trial.

One of the objectives of external radiotherapy is to treat the target—in
this instance the whole breast—with an even dose distribution, i.e.,
within 95%–107% of the prescribed dose. Too low a dose can risk tumor recurrence, and too high a dose can cause undesirable side effects such as skin changes. The researchers tried to determine whether the effect of
using IMRT in those patients who would have received a dose greater than 107% to areas of their breast with 2DRT would translate into clinical benefit. IMRT planning uses results from scans to determine the dose intensity that will best treat the tumor, and therefore is more complex and time-consuming than 2DRT planning, so there was an important need to see a clear advantage to patients from the use of the procedure.

The only prior research looking at this was much smaller, and instead of
selecting all patients with doses greater than 107% and randomizing them, it only included women with larger breasts who are already known to be more likely to have regions of dose above the upper limit. “Our trial was more inclusive as all women were able to take part and we could quantify those who would receive an uneven dose,” said Dr. Coles. “We saw that fewer patients in the IMRT group developed skin telangiectasia, and the overall cosmetic effect in the breast was better,” she said. Although there was no significant difference between the two groups in breast edema, breast shrinkage, breast induration, and pigmentation alterations, the advantages of using IMRT in these patients were obvious. The researchers’ goal is to follow-up their research by studying the patients’ questionnaires to see whether IMRT has an influence on quality of life.

The trial has also contributed 1,000 blood samples to the UK translational
research RAPPER (Radiogenomics: Assessment of Polymorphisms for Predicting the Effects of Radiotherapy) study, which intends to eventually develop individualized radiotherapy plans based on the analysis of individual patients’ genetic composition.

Related Links:

Addenbrooke’s Hospital Oncology Center



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Syringe Pump
SP50 Series
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Design-science framework integrating CML and LLM pipelines for supply chain risk evaluation. (Gupta I, Konduru H, Correa S, et al. A causal analytics approach for interpretable supply chain risk and supplier performance evaluation. Supply Chain Analytics, 2026. doi:10.1016/j.sca.2026.100248)

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. However, artificial intelligence (AI) systems may... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.